Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation | International Journal of Neuropsychopharmacology | Oxford Academic

Posted on by

AbstractBackground. The benefits of low-dose ketamine for patients with treatment-resistant depression (TRD) and prominent suicidal ideation require further inv
— Read on academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyad014/7086173

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s